Néel D, Merlu B, Turpin E, Rabourdin-Combe C, Mach B, Goussault Y, Charron D J
Pathologie et Biologie Moléculaires des Glycoprotéines, U.180 I.N.S.E.R.M., Paris, France.
Biochem J. 1987 Jun 1;244(2):433-42. doi: 10.1042/bj2440433.
In order to determine the factors that influence the glycosylation of an integral membrane protein, we investigated the N-glycosylation of a molecule of the human major histocompatibility complex (MHC) class II, the HLA-DR antigen. This glycoprotein was studied in a human Epstein-Barr-virus-transformed B cell line and in a mouse fibroblastic cell line co-transfected with DR alpha and DR beta genes. We observed that the HLA-DR-antigen glycosylation pattern depends on the cell line in which processing takes place and is closely related to the glycosylation pattern of the overall cellular glycoproteins. Furthermore, when comparing the glycosylation of the separated alpha- and beta-chains, differences were noticed within the same molecule, showing the importance of the individual peptide backbone for the glycosylation process.
为了确定影响整合膜蛋白糖基化的因素,我们研究了人类主要组织相容性复合体(MHC)II类分子HLA-DR抗原的N-糖基化。在人Epstein-Barr病毒转化的B细胞系以及共转染了DRα和DRβ基因的小鼠成纤维细胞系中对这种糖蛋白进行了研究。我们观察到,HLA-DR抗原的糖基化模式取决于进行加工的细胞系,并且与整体细胞糖蛋白的糖基化模式密切相关。此外,在比较分离的α链和β链的糖基化时,在同一分子内发现了差异,这表明单个肽主链在糖基化过程中的重要性。